نتایج جستجو برای: tumor vaccines

تعداد نتایج: 475750  

2015
David M. McDonald Scott N. Byrne Richard J. Payne

Due to changes in glycosyltransferase expression during oncogenesis, the glycoproteins of cancer cells often carry highly truncated carbohydrate chains compared to those on healthy cells. These glycans are known as tumor-associated carbohydrate antigens (TACAs), and are prime targets for use in vaccines for the prevention and treatment of cancer. Herein, we review the state-of-the-art in target...

Journal: :Cancer research 2015
Madiha Derouazi Wilma Di Berardino-Besson Elodie Belnoue Sabine Hoepner Romy Walther Mahdia Benkhoucha Patrick Teta Yannick Dufour Céline Yacoub Maroun Andres M Salazar Denis Martinvalet Pierre-Yves Dietrich Paul R Walker

Vaccines that can coordinately induce multi-epitope T cell-mediated immunity, T helper functions, and immunologic memory may offer effective tools for cancer immunotherapy. Here, we report the development of a new class of recombinant protein cancer vaccines that deliver different CD8(+) and CD4(+) T-cell epitopes presented by MHC class I and class II alleles, respectively. In these vaccines, t...

Journal: :Vaccines 2023

The understanding of the relationship between immunological responses and cancers, especially those related to HPV, has allowed for study development therapeutic vaccines against these neoplasias. There is a growing number studies about composition influence tumor microenvironment (TME) in progression or establishment most varied types cancer. Hence, it been possible structure immunotherapy app...

Journal: :Blood 2008
Cory L Ahonen Anna Wasiuk Shinichiro Fuse Mary Jo Turk Marc S Ernstoff Arief A Suriawinata James D Gorham Ross M Kedl Edward J Usherwood Randolph J Noelle

Identification of Toll-like receptors (TLRs) and their ligands, and tumor necrosis factor-tumor necrosis factor receptor (TNF-TNFR) pairs have provided the first logical, hypothesis-based strategies to molecularly concoct adjuvants to elicit potent cell-mediated immunity via activation of innate and adaptive immunity. However, isolated activation of one immune pathway in the absence of others c...

2014
Yi Lin Thomas Atwell Adam Weisbrod Mary Maas Adam Armstrong Michael Deeds Peggy Bulur Michael Gustafson Zhe Zhang Louis Porrata Svetomir Markovic Patrick Johnston Ivana Micallef David Inwards Joseph Colgan Stephen Ansell Dennis Gastineau Allan Dietz Thomas Witzig

Methods Autologous mature dendritic cells (mDC) were manufactured from leukapheresed cells of NHL patients. For patients with tumor lymph nodes deemed amenable to cryoablation by interventional radiologist (arm A), they received cryoablation of a node and injection of mDC into the cryoablated node followed by another 1 to 7 intratumoral mDC injections. Remaining patients had a tumor excised to ...

Journal: :Vaccines 2023

Cancer is a major public health threat, and researchers are constantly looking for new ways to develop effective treatments. One approach the use of cancer vaccines, which work by boosting body’s immune system fight cancer. The goal this study was an vaccine using rendered-inactive tumor cells. A CMS5 fibrosarcoma model in BALB/c mice E.G7 lymphoma C57BL/6 were used evaluate how mitomycin C-ina...

Journal: :iranian journal of immunology 0
zahra meshkat department of virology, faculty of medical sciences, tarbiat modares university, tehran hoorieh soleimanjahi department of virology, faculty of medical sciences, tarbiat modares university, tehran hessam mirshahabi department of virology, faculty of medical sciences, tarbiat modares university, tehran mojtaba meshkat school of medicine, islamic azad university, mashhad maryam kheiandish blood transfusion center, tehran, iran zuhair mohammad hassan department of virology, faculty of medical sciences, tarbiat modares university, tehran

background: vaccines capable of controlling tumor virus based infections are found difficult to develop due to the consistence latent infection in the host. dna vaccines are attractive tools for the development of hpv vaccines and inducing antigen-specific immunity owing to the stability, simplicity of delivery, safety and cost effectiveness. however, there is a need to increase their potency b...

2014
Xu-Dong Tang Shu-Liang Guo Guo-Zhen Wang Ning Li Yu-Yun Wu Dian-Chun Fang Ya-Han Fan Shi-Ming Yang

Previous studies have indicated that heparanase (Hpa) might represent a candidate universal tumor-associated antigen. However, vaccine therapy targeting only one cytotoxic T lymphocyte (CTL) epitope is suboptimal in preventing cancer. In the present study, we designed heparanase multi-epitope vaccines to increase the immune response to standard single heparanase epitopes. The results showed tha...

Journal: :Cancer research 2004
Samudra K Dissanayake James A Thompson Jacobus J Bosch Virginia K Clements Peter W Chen Bruce R Ksander Suzanne Ostrand-Rosenberg

Mouse tumor cells transfected with syngeneic MHC class II and costimulatory molecule genes are therapeutic vaccines in mice, provided they do not coexpress the class II-associated invariant chain (Ii). We demonstrated previously that the vaccine cells present tumor peptides via the endogenous antigen presentation pathway to activate CD4(+) and CD8(+) T cells. Because of their efficacy in mice, ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید